BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20447905)

  • 1. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
    Cassano P; Argibay P
    Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
    Arantes-Gonçalves F; Coelho R
    Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the molecular treatment of depression].
    Páez X; Hernández L; Baptista T
    Rev Neurol; 2003 Sep 1-15; 37(5):459-70. PubMed ID: 14533097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Affective disorders and antidepressant drugs: Therapeutic innovations].
    Fakra E; Azorin JM; Adida M; Da Fonseca D; Kaladjian A; Pringuey D
    Encephale; 2010 Dec; 36 Suppl 6():S183-7. PubMed ID: 21237354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Depression and neuroplasticity].
    Pitchot W; Polis M; Belachew S; Ansseau M
    Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stress, depression and cerebral plasticity: an update of clinical and experimental findings].
    Allilaire JF; Lôo H
    Bull Acad Natl Med; 2005 May; 189(5):845-50; discussion 850-1. PubMed ID: 16433456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU; Marks DM; Han C; Patkar AA; Steffens D
    Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells.
    Kovaru H; Pav M; Kovaru F; Raboch J; Fiserova A
    Neuro Endocrinol Lett; 2009; 30(4):421-8. PubMed ID: 20010506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From restoration of neuroplasticity to the treatment of depression: clinical experience.
    Costa e Silva JA
    Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S511-21. PubMed ID: 15550350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression.
    Kiss JP
    Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants.
    Piser TM
    Brain Behav Immun; 2010 May; 24(4):515-24. PubMed ID: 20193757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term plasticity of visually evoked potentials in humans is altered in major depression.
    Normann C; Schmitz D; Fürmaier A; Döing C; Bach M
    Biol Psychiatry; 2007 Sep; 62(5):373-80. PubMed ID: 17240361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenomics and future antidepressant research].
    Yamada M
    Seishin Shinkeigaku Zasshi; 2002; 104(10):810-8. PubMed ID: 12607922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New perspectives of the mechanism of action of antidepressants arised from genomic theory of depression].
    Cereseto M; Ferrero A
    Vertex; 2003; 14(51):30-5. PubMed ID: 12690407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.
    Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A
    Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antistress properties of antidepressant drugs and their clinical implications.
    Calabrese F; Molteni R; Riva MA
    Pharmacol Ther; 2011 Oct; 132(1):39-56. PubMed ID: 21640755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular mechanisms in the long-term action of antidepressants.
    Racagni G; Popoli M
    Dialogues Clin Neurosci; 2008; 10(4):385-400. PubMed ID: 19170396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neurobiology of depression].
    Haffen E; Sechter D
    Rev Prat; 1999 Apr; 49(7):707-12. PubMed ID: 10337213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroplasticity and depression].
    Czéh B; Simon M
    Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.